Core & Main (CNM) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
24 Mar, 2026Executive summary
Fiscal 2025 marked the 16th consecutive year of sales growth, with net sales of $7.65 billion, Adjusted EBITDA of $931 million, and Adjusted Diluted EPS of $2.97, reflecting consistent execution and margin improvement.
Broadened product portfolio and expanded footprint through ten new greenfields and two acquisitions (Canada Waterworks and Pioneer Supply), enhancing presence in high-growth markets.
Gross margin expanded by 30 basis points year-over-year to 26.9%, aided by higher private label penetration and disciplined pricing.
Generated $650 million in operating cash flow, supporting investments in organic growth, M&A, and $155 million in share repurchases.
Continued to invest in product categories, footprint, and capabilities to support long-term growth.
Financial highlights
Net sales grew 3% year-over-year to $7.65 billion; adjusted for one less selling week, growth was 5%.
Adjusted EBITDA was $931 million, with margin at 12.2%; Adjusted Diluted EPS increased 7% to $2.97.
Gross profit increased 4% to $2.06 billion; gross margin improved 30 bps to 26.9%.
Net income rose 7% to $462 million; net income margin up 20 bps to 6.0%.
Returned $155 million to shareholders via share repurchases, reducing share count by 3.2 million.
Outlook and guidance
Fiscal 2026 guidance: net sales of $7.8–$7.9 billion (2–3% growth), Adjusted EBITDA of $950–$980 million, margin of 12.2–12.4%, and operating cash flow conversion of 60–70%.
Municipal market expected to remain strong; residential to be down mid-single digits, non-residential flattish.
Anticipates above-market volume growth from sales and geographic expansion, with record 7–10 greenfield openings.
Expects to grow Adjusted EBITDA margins through gross margin initiatives and cost actions.
Capital allocation priorities unchanged: invest in growth, pursue M&A, and continue share repurchases.
Latest events from Core & Main
- Net sales up 11% to $1.74B, but margins narrowed and net income declined on higher costs.CNM
Q1 202531 Jan 2026 - Record Q2 sales from acquisitions offset by lower income and reduced outlook amid market headwinds.CNM
Q2 202522 Jan 2026 - Record Q3 sales, raised outlook, and strong cash flow highlight robust growth and execution.CNM
Q3 202512 Jan 2026 - Record sales and EBITDA in FY24; 2025 outlook strong with growth and stable margins.CNM
Q4 202526 Dec 2025 - Q3 net sales and profit rose, with margin expansion and increased share repurchases.CNM
Q3 202610 Dec 2025 - Record sales, new leadership, and strong governance mark this year's proxy highlights.CNM
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on directors, auditor, and executive pay, all board-backed.CNM
Proxy Filing1 Dec 2025 - Record Q1 sales up 9.8%–10%, margin gains, and FY2025 outlook reaffirmed.CNM
Q1 202610 Nov 2025 - Q2 sales rose 6.6%–7% with strong municipal demand, but 2025 guidance was lowered on higher costs.CNM
Q2 202610 Sep 2025